NTT Data, Pieces Technologies to collaborate
NTT Data Services has partnered with artificial intelligence developer Pieces...Read more on AuntMinnie.comRelated Reading: NTT Data debuts analytics platform, partners with MD.ai NTT Data expands its enterprise imaging portfolio NTT Data partners with Imbio for lung analytics
Fight Aging! provides a weekly digest of news and commentary for thousands of subscribers interested in the latest longevity science: progress towards the medical control of aging in order to prevent age-related frailty, suffering, and disease, as well as improvements in the present understanding of what works and what doesn't work when it comes to extending healthy life. Expect to see summaries of recent advances in medical research, news from the scientific community, advocacy and fundraising initiatives to help speed work on the repair and reversal of aging, links to online resources, and much more. This content is...
This study aimed to describe recipients ’ characteristics, and the frequency and etiology of infections and transplant outcome in liver and lung SOTs, and to investigate exposures associated to infection and death in liver transplant recipients. The study population included recipients of SOTs performed in Italy during a 1-year period i n ten Italian lung transplant units and eight liver transplant units. Data on comorbidities, infections, retransplantation, and death were prospectively collected using a web-based system, with a 6-month follow-up. The cumulative incidence of infection was 31.7% and 47.8% in liver and...
No abstract available
Short-term outcomes of solid organ transplantation have improved dramatically over the past several decades; however, long-term survival has remained static over the same period, and chronic rejection remains a major cause of graft failure. The importance of donor, or “passenger,” lymphocytes to the induction of tolerance to allografts was recognized in the 1990s, but their precise contribution to graft acceptance or rejection has not been elucidated. Recently, specialized populations of tissue-resident lymphocytes in nonlymphoid organs have been described. These lymphocytes include tissue-resident memory T cel...
Conclusions Induction with sc28AT promotes early cardiac allograft protection in hu5C8-treated NHPs. These results support further investigation of prolonged selective CD28 inhibition with CD40/CD154 blockade in NHP transplants.
Conclusions Less invasive retransplantation of the lung via sternum-sparing anterolateral thoracotomies and off-pump is a safe procedure with low associated morbidity and favorable midterm survival.
Heart failure results in significant morbidity and mortality for young children with hypoplastic left heart syndrome (HLHS) following the Norwood procedure.
Incompatibility to HLA antigens was the sentinel barrier which historically limited solid organ transplantation. The development of the complement dependent cytotoxicity (CDC) assay by Terasaki half a century ago allowed estimation of rejection risk at transplantation.1 Subsequent emergence of effective immunosuppressive regimens led to significant expansion of transplantation as a suitable therapeutic option for end-stage organ disease. In heart transplantation, the resulting improvement in outcomes has led to a corresponding broadening of the indications for transplant.
The optimal strategy for prevention of invasive fungal infections in lung transplant recipients remains undetermined. We studied a bronchoalveolar lavage fungal culture and galactomannan based strategy for prevention of invasive aspergillosis in lung transplant recipients
In this study, 36 people with severe scleroderma received stem-cell transplantation and were compared with 39 otherwise similar people who received a year of standard immune-suppressing medication. After 4.5 years, those assigned to receive stem-cell transplantation had improved overall survival compared with standard treatment (79% vs. 50%) less need for immune-suppressing medication (9% vs. 44%) fewer deaths related to worsening scleroderma (11% vs. 28%) more deaths related to treatment — (3% vs. 0%). These findings suggest that stem-cell transplantation may be much better than standard treatment for people with ...
More News: Lung Transplant